Synbio Tech (ROCO:1295) Short-Term Debt: NT$631 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1295 Synbio Tech Inc ROCO:1295
57 GF Score
Price NT$45.60
GF Value NT$82.46
Valuation Possible Value Trap
! 12 Warning Signs
View Full Analysis

What is Synbio Tech Short-Term Debt?

Synbio Tech ROCO:1295 -0.55% 57 Short-Term Debt is NT$631 Mil as of Jun. 2026. GuruFocus rates ROCO:1295 with a GF Score™ of 57/100 and a GF Value™ of NT$82.46 (Possible Value Trap). The stock has 12 warning signs investors should review.

Synbio Tech's Short-Term Debt for the quarter that ended in Jun. 2026 was NT$631 Mil.

Synbio Tech's quarterly Short-Term Debt increased from Dec. 2025 (NT$336 Mil) to Mar. 2026 (NT$604 Mil) and increased from Mar. 2026 (NT$604 Mil) to Jun. 2026 (NT$631 Mil).

Synbio Tech's annual Short-Term Debt increased from Dec. 2023 (NT$28 Mil) to Dec. 2024 (NT$161 Mil) and increased from Dec. 2024 (NT$161 Mil) to Dec. 2025 (NT$336 Mil).

Synbio Tech Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Synbio Tech Short-Term Debt Related Terms

Synbio Tech Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Synbio Tech's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synbio Tech Short-Term Debt Chart

Synbio Tech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial 186.26 85.26 27.57 161.42 336.12

Synbio Tech Quarterly Data
Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 308.26 305.95 336.12 603.63 630.51
ROCO:1295
57GF Score
Synbio Tech Inc ROCO:1295
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of NT$631 Mil mean?
Synbio Tech (ROCO:1295) has a Short-Term Debt of NT$631 Mil as of Jun. 2026.
Is Synbio Tech's Short-Term Debt too high?
Synbio Tech's current Short-Term Debt is NT$631 Mil. Overall, Synbio Tech has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Short-Term Debt compare to VRTX and REGN?
Synbio Tech's Short-Term Debt of NT$631 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Synbio Tech's current Short-Term Debt is NT$631 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Based on GuruFocus' analysis, Synbio Tech (ROCO:1295) is currently considered Possible Value Trap. The stock's GF Value™ is NT$82.46, compared to a current price of NT$45.60 — trading 44.7% below its estimated fair value. The current Short-Term Debt is NT$631 Mil. Synbio Tech's overall GF Score™ is 57/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Short-Term Debt is NT$631 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synbio Tech (ROCO:1295) Overvalued in 2026?

Based on GuruFocus' analysis, Synbio Tech stock appears to be undervalued. The current stock price of NT$45.60 is trading 44.7% below its estimated GF Value™ of NT$82.46. GuruFocus considers Synbio Tech to be Possible Value Trap.

Key valuation signals for ROCO:1295:

  • Short-Term Debt: NT$631 Mil
  • GF Value™: NT$82.46 vs. price of NT$45.60 (44.7% below fair value)
  • GF Score™: 57/100 with 12 warning signs

No single metric tells the full story. See the ROCO:1295 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synbio Tech Business Description

Address No.82, Beiling 6th Road, Luzhu District, Kaohsiung, TWN, 821
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
57GF Score

Get the complete analysis for ROCO:1295

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$45.60
Price
NT$82.46
GF Value